NCT02283983View on ClinicalTrials.gov

Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose

NACompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2019

Study Completion Date

June 25, 2020

Conditions
Breast Neoplasms
Interventions
OTHER

mittens and booties

OTHER

cooling helmet

Trial Locations (10)

44202

Centre Catherine de Sienne, Nantes

44606

Clinique Mutualiste de l'Estuaire, Saint-Nazaire

44805

Institut de cancérologie de l'Ouest - Nantes, Saint-Herblain

49300

Centre Hospitalier de Cholet, Cholet

49933

Institut de cancérologie de l'Ouest - Angers, Angers

56000

Centre d'Oncologie Saint-Yves, Vannes

CHBA Vannes, Vannes

56100

Centre hospitalier Bretagne Sud, Lorient

72000

CH du Mans, Le Mans

85925

CHD Vendee, La Roche-sur-Yon

All Listed Sponsors
lead

Centre Hospitalier Departemental Vendee

OTHER

NCT02283983 - Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose | Biotech Hunter | Biotech Hunter